Drugs that contain Gabapentin Enacarbil

1. List of Horizant drug patents

HORIZANT's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8048917 AZURITY Prodrugs of GABA analogs, compositions and uses thereof
Nov, 2022

(4 months ago)

US6818787 AZURITY Prodrugs of GABA analogs, compositions and uses thereof
Apr, 2025

(2 years from now)

US8026279 AZURITY Crystalline form of γ-aminobutyric acid analog
Nov, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8686034 AZURITY Crystalline form of γ-aminobutyric acid analog
Jan, 2025

(1 year, 9 months from now)

US8114909 AZURITY Treating or preventing restless legs syndrome using prodrugs of GABA analogs
Apr, 2026

(3 years from now)

US8795725 AZURITY GABA analog prodrug sustained release oral dosage forms
Jun, 2029

(6 years from now)

Market Authorisation Date: 06 April, 2011

Treatment: Treatment of moderate-to-severe primary restless leg syndrome in adults; Management of postherpetic neuralgia (phn) in adults

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of HORIZANT before it's patent expiration?
More Information on Dosage

HORIZANT family patents

54

United States

11

Japan

10

China

10

European Union

9

Australia

8

Korea, Republic of

7

Norway

6

Israel

6

New Zealand

5

South Africa

5

Mexico

5

Hong Kong

5

Canada

4

Russia

4

Spain

3

Denmark

3

Austria

3

Brazil

2

Hungary

2

Singapore

2

Portugal

2

Cyprus

1

Slovenia

1

Germany

1

Poland

1

Taiwan, Province of China

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic